Table 2 Medications at discharge.
Variable | Overall Study Population | Male | Female | p Value |
|---|---|---|---|---|
n = 6063 | n = 2843 | n = 3220 | ||
ASA, N (%) | 5206 (85.9) | 2411 (84.8) | 2795 (86.8) | 0.021 |
P2Y12 inhibitors, N (%) | 3750 (61.9) | 1709 (60.1) | 2041 (63.4) | 0.010 |
ACE inhibitors, N (%) | 4230 (69.8) | 1976 (69.5) | 2254 (70.0) | 0.670 |
Beta-adrenolytics, N (%) | 4657 (76.8) | 2149 (75.6) | 2508 (77.9) | 0.031 |
Statins, N (%) | 4905 (81.0) | 2232 (78.5) | 2673 (83.0) | < 0.001 |
Nitrates, N (%) | 575 (9.5) | 279 (9.8) | 296 (9.2) | 0.449 |
LWMH, N (%) | 289 (4.7) | 154 (5.4) | 135 (4.2) | 0.029 |
Oral anticoagulants, N (%) | 356 (5.9) | 176 (6.2) | 180 (5.6) | 0.341 |
